Skip to main content

Table 3 Investigatorsa in the Pregabalin Adolescent Fibromyalgia Study Group

From: Safety and efficacy of pregabalin in adolescents with fibromyalgia: a randomized, double-blind, placebo-controlled trial and a 6-month open-label extension study

Investigator Institution
Anthony Alario University of Massachusetts Memorial Medical Center, Worcester, MA, United States
Sushrut Sudhir Babhulkar Sushrut Hospital, Research Centre & Post Graduate Institute of Orthopedics, Nagpur, India
Ramon Berenguer Florida Medical Center & Research, Inc., Miami, FL, United States
Pamela Freeman Rheumatology Associates of Central Florida, Orlando, FL, United States
Jeffrey Gold Children’s Hospital Los Angeles, Los Angeles, CA, United States
Steven Goodman Delray Research Associates, Delray Beach, FL, United States
Hana Jarosova Bioregeneracni a rehabilitacni centrum, Ricany, Czech Republic
Wendy Lee South Carolina Research Center, Myrtle Beach, SC, United States
Jonathan Liss Medical Research & Health Education Foundation, Inc. Columbus, GA, United States
Svetlana Lvovich St. Christopher's Hospital for Children, Philadelphia, PA, United States
Adonis Maiquez Harmony Clinical Research Inc., North Miami Beach, FL, United States
Nabil Morcos Apex Research Institute, Santa Ana, CA, United States
Shankara Nellikunja Mallikatta Neuro Centre, Mangalore, India
Murray Passo Medical University of South Carolina, Charleston, SC, United States
Laura Schanberg Duke University Medical Center, Durham, NC, United States
Vijai Prakash Sharma King George’s Medical University, Lucknow, India
Charles Spencer Nationwide Children's Hospital, Columbus, OH, United States
Mary Toth Akron Children's Hospital, Akron, OH, United States
Sarath Chandra Mouli Veeravalli Krishna Institute of Medical Sciences Ltd, Secunderabad, India
Wen-Chin Weng National Taiwan University Hospital, Taipei, Taiwan
  1. a Investigators listed in alphabetical order by last name